Brief: Ainos Announces Positive Results From Preclinical Studies Of Its Low-Dose Oral Interferon Formulation Against Covid-19

Ainos

27/06/2022 12:05

June 27 (Reuters) - Ainos Inc  AIMD.PK :
    * AINOS ANNOUNCES POSITIVE RESULTS FROM PRECLINICAL STUDIES
OF ITS
LOW-DOSE ORAL INTERFERON FORMULATION AGAINST COVID-19
    * AINOS INC - HAMSTERS RECEIVING AINOS' VELDONA FORMULATION
DEMONSTRATE PROTECTION FROM COVID-19 BASED ON PRESPECIFIED
INDICATORS OF CLINICAL OUTCOMES
    * AINOS INC - COMPANY WILL BEGIN TO PREPARE APPLICATION
DOCUMENTS
FOR U.S. FDA PHASE 2/3 CLINICAL TRIALS

Source text for Eikon:  ID:nPn9dgsLNa 
Further company coverage:  AIMD.PK 

 ((Reuters.Briefs@thomsonreuters.com;))